Print Email  

For Researchers

Research is crucial to PPMD’s goal of ending Duchenne. As the Duchenne research landscape has broadened dramatically since PPMD was founded in 1994, so has our research strategy. Our focus is a balance of basic, translational and later stage projects that will help accelerate clinical trials and find a cure for Duchenne. PPMD leads the Duchenne community in advocacy, funding, and community building. We bring together money, patients, and professionals where they can all be the most effective.

PPMD is the only muscular dystrophy research organization:

  • To invest in a broad research portfolio.
  • To explore short-, mid-, and long-term treatments and therapies.
  • To leverage $200 million into research centers and $22 million into Duchenne-specific programs at the Centers for Disease Control.
  • To leverage $15.4 million from the National Institute of Health (NIH) into PPMD’s drug discovery program.

In early 2008, PPMD launched DuchenneConnect, which brings together all members of the Duchenne community: patients, families, and medical and research professionals.

In this section

Funding Opportunities
Standard Operating Procedures (SOP's) for Duchenne Animal Models

Facebook YouTube Twitter

Our family-centered approach is at the heart of everything we do. Learn more.